LANNETT REPORTS FISCAL 2022 SECOND-QUARTER FINANCIAL RESULTS; REVISES DOWN FULL-YEAR GUIDANCE

/PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2022 second quarter ended December 31, 2021. "For the...

Related Keywords

United States ,Canada ,Philadelphia ,Pennsylvania ,Robert Jaffe ,Advair Diskus ,Glaxosmithkline ,Lannett Company ,Kremers Urban Pharmaceuticals Inc ,Exchange Commission ,Recro Gainesville ,Lannett Company Inc ,Robert Jaffe Co ,Tim Crew ,Investigational New Drug ,Biologics License Application ,Abbreviated New Drug Application ,Cost Reduction Initiatives ,Quarter Financial Results ,Call Information ,Chief Information ,Kremers Urban Pharmaceuticals ,Nc ,Health Care Amp Hospitals ,Pharmaceuticals ,Medical Pharmaceuticals ,Earnings ,Earnings Forecasts Amp Projections ,